SPINOGENIX
Spinogenix is a developer of a new class of therapeutics for neurodegenerative and psychiatric diseases. The company is focused on regenerating synapses to reverse declines in cognitive and motor function. They envision the use of SPGs as a monotherapy or in combination with other therapeutics that target disease-specific degenerative processes. Spinogenix's mission is to create transformative therapeutics for diseases involving synaptic loss and dysfunction. It was founded in 2016 and is headquartered in San Diego, California.
SPINOGENIX
Social Links:
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2016-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.spinogenix.com
Total Employee:
1+
Status:
Active
Contact:
858-263-3252
Email Addresses:
[email protected]
Total Funding:
14.41 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Font Awesome Global Site Tag ReCAPTCHA Organization Schema
Similar Organizations
Anagin
Anagin is developing first-in-class therapies for treating neuropsychiatric diseases.
Clene Nanomedicine
Clene Nanomedicine focuses on the development of unique therapeutics for neurodegenerative diseases.
Convalesce
Stem Cell Based Therapy for Neurodegenerative diseases
Enleofen Bio Pte Ltd
Enleofen is a developer of bio technology designed for the treatment of fibro-inflammatory diseases.
ImmunoForge
ImmunoForge is a developer of a new drug intended for treating sarcopenia and cancer.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Viking Therapeutics
Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.
Vivreon Biosciences
Vivreon Biosciences is developing a new class of small molecule therapeutics for the treatment of chronic diseases.
Current Employees Featured
Founder
Investors List
U.S. Department of Defense
U.S. Department of Defense investment in Grant - Spinogenix
National Institutes of Health
National Institutes of Health investment in Grant - Spinogenix
Official Site Inspections
http://www.spinogenix.com Semrush global rank: 4.21 M Semrush visits lastest month: 2.37 K
- Host name: 1359923.cloudwaysapps.com
- IP address: 45.55.155.42
- Location: Clifton United States
- Latitude: 40.8364
- Longitude: -74.1403
- Metro Code: 501
- Timezone: America/New_York
- Postal: 07014
More informations about "Spinogenix"
Spinogenix - Crunchbase Company Profile & Funding
Organization. Spinogenix . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Spinogenix's mission is to create transformative …See details»
Spinogenix is pioneering therapeutics that restore …
Spinogenix’s first-in-human Phase 1/2 study in Australia is fully enrolled and not recruiting. Alzheimer’s Disease The Australia Human Research Ethics Committees has approved the initiation of Spinogenix’s Phase 2 study in …See details»
Team - Spinogenix
Team Executive Team Stella Sarraf, PhD CEO, Founder, DirectorSEE BIO Peter Vanderklish, PhD Chief Science OfficerSEE BIO Craig Erickson, MD Chief Medical AdvisorSEE BIO Sharron Gargosky, PhD Chief Clinical OfficerSEE …See details»
Spinogenix 2025 Company Profile: Valuation, Funding & Investors
Spinogenix was founded in 2016. Where is Spinogenix headquartered? Spinogenix is headquartered in San Diego, CA. What is the size of Spinogenix? Spinogenix has 7 total …See details»
Spinogenix Inc · Spinogenix, Inc. · 4225 Executive Sq Ste
SPINOGENIX, INC. (doing business as SPINOGENIX INC) is an entity in La Jolla, California registered with the System for Award Management (SAM) of U.S. General Services …See details»
Spinogenix, Inc. - LinkedIn
Spinogenix, Inc. | 1,100 followers on LinkedIn. Developing a new class of therapeutics for neurodegenerative and psychiatric diseases | Who we are In most neurodegenerative diseases we lose ...See details»
Spinogenix Company Profile - Office Locations, Competitors
Spinogenix is a company that provides therapeutics restoring the brain connections and functions lost in brain injury and neurodegenerative diseases. It is engaged in the development of drugs …See details»
Spinogenix - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 4, 2025 Spinogenix. has raised a total funding of $8.6M over 4 rounds. Its first funding round was on May 03, 2018. List of recent funding rounds of Spinogenix. Date of funding. Funding …See details»
SPINOGENIX, INC - VentureRadar
Spinogenix is developing a new class of therapeutics to help restore the brain connections and functions lost in brain injury and neurodegenerative diseases. Bio tech-Careers. Associated …See details»
Spinogenix, Inc. - Drug pipelines, Patents, Clinical trials
About Spinogenix Spinogenix is dedicated to developing transformative therapeutics for conditions involving the loss or dysfunction of synapses. Our lead clinical-stage synaptic regenerative candidate is a first-in-class therapeutic …See details»
Spinogenix - Overview, News & Similar companies | ZoomInfo.com
Apr 15, 2024 Spinogenix was founded in 2016 with the mission to develop transformative therapeutics for diseases involving synaptic loss and dysfunction. Our dr ugs are designed to …See details»
Spinogenix - Funding, Financials, Valuation & Investors - Crunchbase
Spinogenix is a developer of a new class of therapeutics for neurodegenerative and psychiatric diseases. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. ... How much …See details»
Companies To Watch: Spinogenix - lifescienceleader.com
Oct 18, 2024 Spinogenix has benefited from close collaboration with academic institutions and has used grant funding to de-risk the company, says Sarraf. “All of our animal work was done …See details»
Spinogenix - Contacts, Employees, Board Members, Advisors
Spinogenix is a developer of a new class of therapeutics for neurodegenerative and psychiatric diseases. New. Resources. Advanced Search ... Experience the new Crunchbase, powered by …See details»
Spinogenix Announces Open Enrollment for Phase 2 US Trial …
1 day ago Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics that restore synapses to improve the lives of patients worldwide, today …See details»
Clinical Trials - Spinogenix
Spinogenix strongly urges you to seek professional medical advice and guidance as to legal, safe and approved treatments for your disease. Alzheimer's Disease We are currently recruiting for …See details»
Spinogenix - zoonop.com
Spinogenix was founded in 2016 by Dr. Stella Sarraf, leveraging her extensive experience in pharmaceuticals and venture capital. She established Spinogenix with the vision of developing …See details»
Spinogenix Announces Open Enrollment for Phase 2 US Trial …
1 day ago Spinogenix CEO and Founder Dr. Stella Sarraf stated, "We are thrilled at the possibility of bringing an entirely new approach to treating schizophrenia for people battling …See details»
Spinogenix Announces FDA Clearance of IND Application for …
May 29, 2024 Spinogenix is dedicated to developing transformative therapeutics for conditions involving the loss or dysfunction of synapses. Our lead clinical-stage synaptic regenerative …See details»
Fragile X Treatment Gets Fast Track Designation
Jan 14, 2025 The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to SPG601, a treatment for people with Fragile X syndrome (FXS) made by the Los Angeles …See details»